This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Carolina Alarco
Founder and Principal, Bio Strategy Advisors, LLC; Co-Founder, Latinos in Bio at Bio Strategy Advisors, LLC and Latinos in Bio

Profile

Carolina Alarco has more than 25 years of experience in the biopharmaceutical industry in Cambridge, Massachusetts. Carolina is the Founder and Principal at Bio Strategy Advisors LLC, a strategic business consulting firm servicing small and medium-sized Biotech companies, specializing in biotech start-up corporate strategy, commercial planning, geographic expansion, go-to-market models and alliance deals. Carolina is also a top-tier Founding Venture Partner at AccelHUB Venture Partners. She plays a central role in the selection, deal execution and initial build of high-quality startups. Prior to this, Carolina was the President of Global Marketing and International Markets at Novelion Therapeutics and Aegerion Pharmaceuticals. Carolina spent 15 years in progressive P&L leadership roles at Genzyme Corporation, where she was a Vice-President for her last 5 years in the company. She played a pivotal role in several product launches globally, new market development and geographical expansion. Her passion is to bring innovative therapies or technologies to patients in need around the world. Carolina also has a strong philanthropic focus. She currently serves as a Founding Member and Past-Chair of the Latino Council at Boston Children’s Hospital and as Board Member of the CURE Rare Disease Foundation. She is co-founder and member of the Steering Committee of Latinos in Bio. She has recently been appointed by Governor Baker to the Massachusetts STEM Advisory Council. She holds a BS in Business Administration from the University of Lima and a Graduate Degree in Business and Management from Harvard University.

Agenda Sessions

  • Panel Discussion

    2:15pm